Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.062 AUD | +3.33% |
|
+1.64% | -22.50% |
Business Summary
Sales per Business
AUD in Million | 2023 | Weight | 2024 | Weight | Delta |
---|---|---|---|---|---|
Focal Adhesion Kinase
100.0
%
| 0 | 100.0 % | 0 | 100.0 % | -63.46% |
Sales per region
AUD in Million | 2023 | Weight | 2024 | Weight | Delta |
---|---|---|---|---|---|
Australia
100.0
%
| 0 | 100.0 % | 0 | 100.0 % | -63.46% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Founder | - | 00-05-30 | |
Tim Luscombe
DFI | Director of Finance/CFO | - | 23-09-24 |
Rhiannon Jones
COO | Chief Operating Officer | - | 21-01-31 |
Charlotte Mulder
PRN | Corporate Officer/Principal | - | - |
Mark Devlin
PRN | Corporate Officer/Principal | - | - |
Andrew Cooke
SEC | Corporate Secretary | 62 | 13-10-10 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Andrew Cooke
SEC | Corporate Secretary | 62 | 13-10-10 |
Robert Peach
BRD | Director/Board Member | 68 | 15-09-01 |
Warwick Tong
CHM | Chairman | - | 18-05-03 |
Founder | - | 00-05-30 | |
Jane Bell
BRD | Director/Board Member | - | 21-04-11 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 271,608,953 | 210,176,337 ( 77.38 %) | 0 | 77.38 % |
Company contact information
![address Amplia Therapeutics Limited(ATX)](https://cdn.zonebourse.com/static/address/46178167.png)
Sector
1st Jan change | Capi. | |
---|---|---|
-22.50% | 11.44M | |
+20.12% | 126B | |
+25.25% | 119B | |
+25.56% | 27.95B | |
-19.51% | 20.5B | |
-14.36% | 17.12B | |
-15.63% | 16.1B | |
-46.67% | 14.97B | |
+11.89% | 14.84B | |
+57.74% | 14.38B |
- Stock Market
- Equities
- ATX Stock
- Company Amplia Therapeutics Limited